In Botswana, the pregnant women living with hiv antiretroviral therapy coverage for pmtct stands at 98%, reflecting an increase of 1% (1.0%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Botswana
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Botswana
PMTCT antiretroviral therapy coverage
More indicators for Botswana
Male unintentional poisoning
2.1
-0.2
(2019)
Female wasting in children
7.1%
+1.6%
(2007)
Female prevalence of HIV
5.3%
-0.6%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar47
+intl dollar4
(2021)
Birth registration
87.5%
+4.3%
(2017)
Contraceptive modern method prevalence
42.1%
-3.6%
(2000)
Botswana PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 98% | +1% |
| 2021 | 97% | -3% |
| 2020 | 100% | 0% |
| 2019 | 100% | +2% |
| 2018 | 98% | +9% |
| 2017 | 89% | +11% |
| 2016 | 78% | -1% |
| 2015 | 79% | +4% |
| 2014 | 75% | -7% |
| 2013 | 82% | +1% |
| 2012 | 81% | +17% |
| 2011 | 64% | -6% |
| 2010 | 70% | -9% |
| 2009 | 79% | +7% |
| 2008 | 72% | 0% |
| 2007 | 72% | -5% |
| 2006 | 77% | +10% |
| 2005 | 67% | +25% |
| 2004 | 42% | +9% |
| 2003 | 33% | +8% |
| 2002 | 25% | +9% |
| 2001 | 16% | +8% |
| 2000 | 8% |